Congratulations to the Myrtelle team on this exciting announcement. We are proud to be supporting your work and to be part of the journey, bringing hope to the patients and families affected by Canavan disease.
Myrtelle launches commercial-stage manufacturing with Charles River and Viralgen for its first-in-class gene therapy targeting Canavan disease. Read more: https://lnkd.in/e5BHsZ9x #HopeInProgress #Biotech Viralgen Charles River Laboratories
